SQSTM1 and Alzheimer disease: Among the four groups, the positive rate of p62 was low in PART with Braak NFT stage I/II, moderate in PART with Braak NFT stage I _I _I/IV, which was close to that of pre-AD, and high in AD with Braak stage V/VI.